statements

RJ Bio-Tech Ltd.

BSE: 536456

Sector: Fast Moving Consumer Goods

Industry Group: Agricultural Food & other Products

Industry: Other Agricultural Products

-+0.0 (+0.00%)

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

RJ Bio-Tech Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	9.11	13.44	16.10	19.85	28.68	31.67	35.96	15.74	8.89	10.12	13.38	15.80	13.90
Cost of Operating Revenue	3.16	4.34	5.33	6.97	9.11	8.73	14.49	12.67	7.97	6.40	6.31	15.19	6.63
Gross Profit	5.95	9.10	10.76	12.88	19.57	22.93	21.47	3.07	0.92	3.72	7.07	0.61	7.27
Gross Margin	65.3	67.7	66.9	64.9	68.2	72.4	59.7	19.5	10.4	36.7	52.9	3.8	52.3
Total Operating Expenses	7.74	11.11	13.26	16.21	23.06	26.50	30.13	27.10	16.96	17.65	16.96	28.51	12.65
Operating Profit	1.37	2.34	2.84	3.65	5.63	5.17	5.83	-11.36	-8.07	-7.53	-3.58	-12.71	1.24
Operating Margin	15.1	17.4	17.6	18.4	19.6	16.3	16.2	-72.2	-90.9	-74.4	-26.7	-80.5	8.9
Financing Income/(Expense) - Net	-0.94	-1.72	-2.03	-2.34	-2.64	-3.60	-3.44	-3.60	-3.89	-4.14	-0.78	0.00	-5.82
Profit before Taxes	0.44	0.62	0.80	1.30	2.87	1.46	2.28	-15.02	-20.77	-11.53	-4.16	-15.68	-4.05
Income Taxes	0.04	0.20	0.26	0.00	-	-	0.01	0.00	-	-	-	-	-
Profit after Tax	0.40	0.41	0.54	1.30	2.87	1.46	2.27	-15.02	-20.77	-11.53	-4.16	-15.68	-9.16
PAT Margin	4.4	3.1	3.4	6.6	10.0	4.6	6.3	-95.4	-233.7	-114.0	-31.1	-99.3	-65.9
EPS - Basic - ex Extraordinary Items	0.47	0.49	0.64	1.38	3.48	1.55	2.40	-15.86	-21.93	-12.18	-4.39	-16.56	-9.67
EPS - Diluted - ex Extraordinary Items	0.47	0.49	0.64	1.38	3.48	1.55	2.40	-15.86	-21.93	-12.18	-4.39	-16.56	-9.67
EBIT	1.37	2.34	2.84	3.65	5.63	5.17	5.83	-11.36	-8.07	-7.53	-3.58	-12.71	1.24
EBITDA	1.58	2.70	3.22	4.01	5.95	5.76	6.15	-11.04	-7.89	-7.38	-3.48	-12.62	1.31
EBITDA Margin	17.3	20.1	20.0	20.2	20.8	18.2	17.1	-70.2	-88.7	-72.9	-26.0	-79.9	9.4

Balance Sheet

Abridged

Understanding Balance Sheet

RJ Bio-Tech Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31

Source:	PR	PR	PR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	12.06	22.25	32.14	34.61	52.29	56.04	55.27	43.51	31.50	24.34	22.10	3.63	0.29
Property Plant & Equipment - Net	2.70	2.86	3.05	2.91	2.99	2.41	2.12	1.95	1.84	1.75	1.72	1.75	1.53
Total Non-Current Assets	5.26	5.38	6.41	5.95	5.72	4.82	4.62	4.03	3.57	3.44	3.32	2.23	1.63
Total Assets	17.32	27.62	38.55	40.56	58.01	60.87	59.89	47.53	35.08	27.78	25.41	5.86	1.92
Total Current Liabilities	8.53	16.03	22.81	22.47	32.45	34.18	32.87	34.27	39.04	43.21	45.04	42.71	48.35
Long Term Debt	3.04	3.19	3.30	3.14	2.47	1.91	0.04	1.47	5.26	5.38	5.20	3.64	3.32
Total Non-Current Liabilities	3.54	3.97	4.39	3.61	3.21	2.98	1.05	2.31	5.85	5.92	5.87	4.34	3.91
Total Liabilities	12.08	20.00	27.19	26.08	35.66	37.17	33.92	36.58	44.89	49.12	50.92	47.04	52.26
Total Shareholders' Equity	5.24	7.62	11.36	14.48	22.35	23.70	25.97	10.95	-9.81	-21.34	-25.50	-41.18	-50.34
Total Equity	5.24	7.62	11.36	14.48	22.35	23.70	25.97	10.95	-9.81	-21.34	-25.50	-41.18	-50.34
Total Liabilities & Equity	17.32	27.62	38.55	40.56	58.01	60.87	59.89	47.53	35.08	27.78	25.41	5.86	1.92

Cash Flow

Abridged

Understanding Cash Flow Statement

RJ Bio-Tech Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	1.57	2.07	3.59	3.98	5.28	3.91	4.20	-13.59	-19.49	-10.63	-3.36	-11.26	-8.56
Working Capital - Increase/(Decrease)	-2.81	-7.47	-8.94	-2.44	-13.05	-5.04	-1.86	10.05	12.92	7.33	3.28	13.22	-1.98
Net CF from Operating Activities	-1.24	-5.40	-5.35	1.54	-7.77	-1.13	2.35	-3.53	-6.57	-3.30	-0.08	1.96	-10.53
Capital Expenditures - Net	1.07	0.50	0.56	0.21	0.41	0.12	0.03	-0.02	0.08	0.06	0.07	0.11	-
Net CF from Investing Activities	-3.14	-1.65	-3.94	-2.37	-2.18	-1.66	-1.35	-0.84	-0.82	-0.77	-0.67	-0.37	-
Stock - Issuance/(Retirement) - Net	0.68	1.97	3.19	1.08	5.00	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	3.73	5.66	6.31	-1.41	5.28	2.64	-1.40	4.42	7.34	4.11	0.72	-1.54	10.49
Net Cash Flow from Financing Activities	4.42	7.62	9.50	-0.33	10.29	2.64	-1.40	4.42	7.34	4.11	0.72	-1.54	10.49
Free Cash Flow to Equity	1.42	-0.24	0.40	-0.08	-2.89	1.40	0.91	0.90	0.69	0.75	0.58	0.31	-0.04
Free Operating CF net dividend	-2.31	-5.90	-5.92	1.32	-8.18	-1.25	2.31	-3.63	-6.69	-3.37	-0.14	1.84	-10.53
Free Operating CF	-2.31	-5.90	-5.92	1.32	-8.18	-1.25	2.31	-3.63	-6.69	-3.37	-0.14	1.84	-10.53

Business Segment Analysis

RJ Bio-Tech Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for RJ Bio-Tech Ltd.

Regional Segment Analysis

RJ Bio-Tech Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for RJ Bio-Tech Ltd.

Historical Segment Analysis

Track how RJ Bio-Tech Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for RJ Bio-Tech Ltd.

Frequently Asked Questions

What is the revenue of RJ Bio-Tech Ltd.?

The latest trailing twelve month revenue of RJ Bio-Tech Ltd. is -. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of RJ Bio-Tech Ltd.?

The latest trailing twelve month net profit (PAT) of RJ Bio-Tech Ltd. is -. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of RJ Bio-Tech Ltd.?

The operating margin of RJ Bio-Tech Ltd. is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of RJ Bio-Tech Ltd.?

The trailing twelve month Earnings Per Share (EPS) of RJ Bio-Tech Ltd. is -. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of RJ Bio-Tech Ltd.?

The debt-to-equity ratio of RJ Bio-Tech Ltd. stands at -. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of RJ Bio-Tech Ltd.?

The book value per share of RJ Bio-Tech Ltd. is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of RJ Bio-Tech Ltd.?

Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does RJ Bio-Tech Ltd. report consolidated or standalone financials?

RJ Bio-Tech Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.